Clinical Trial Update: Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

View source ↗

Summary

This clinical trial update discusses persistence and adherence, quality of life, and treatment satisfaction among patients using the Avonex PEN for multiple scl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED